In mouse models, co-injection of Nrf2-deficient PSCs with KPC mouse-derived pancreatic cancer cells resulted in the formation of smaller subcutaneous tumors compared to wild-type PSC co-injections (55). Here, NFE2L2 is linked to familial pancreatic carcinoma.